Profound Medical Corp reports results for the quarter ended June 30 - Earnings Summary

• Profound Medical Corp PRN.TO reported a quarterly adjusted loss of 52 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -28 cents. The mean expectation of five analysts for the quarter was for a loss of 37 cents per share. Wall Street expected results to range from -47 cents to -28 cents per share.

• Revenue fell 1% to $2.21 million from a year ago; analysts expected $3.41 million.

• Profound Medical Corp's reported EPS for the quarter was a loss of 52 cents​.

• The company reported a quarterly loss of $15.7 million.

• Profound Medical Corp shares had fallen by 7.6% this quarter and lost 27.4% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• Wall Street's median 12-month price target for Profound Medical Corp is $11.13, about 51% above its last closing price of $5.45

This summary was machine generated from LSEG data August 14 at 09:00 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)